Abstract Submission and Registration Open for Lausanne!Abstract Submission and Early Registration are now open for "Changing the Face of Modern Medicine: Stem Cells and Gene Therapy,"
16-19 October, 2018 in Lausanne, Switzerland.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Join the ISSCR for “Changing the Face of Modern Medicine: Stem Cells & Gene Therapy” from 16-19 October, 2018 in beautiful Lausanne, Switzerland. In collaboration with the European Society for Gene Therapy (ESGCT), the French Society of Gene Therapy (SFTCG), and local organizers in Switzerland, we will welcome a diverse slate of international speakers for three days of talks, poster presentations, and networking opportunities the explore the translation of stem cell research to the clinic.
Registration is now open! Register today to take advantage of the best rates.
"Changing the Face of Modern Medicine: Stem Cells and Gene Therapy" will offer four days of compelling talks, poster presentations, and networking events that highlight the translational process. From basic stem cell research to treatments in the clinic, this collaborative event between the ISSCR and ESGCT will bring insight and perspective to the broad scope of stem cell and regenerative medicine.
The scientific program includes 25 plenary and concurrent sessions with renowned international speakers, as well as opportunities for abstract-selected speakers to present the latest research. In addition, numerous pre-meeting sessions include a Clinical Trial and Commercialization workshop; a Regulatory workshop (sponsored by Merck); and an Education Day for scientists new to regenerative medicine. Full program to publish soon.
- Opening Keynote and Outstanding Achievement Award
- From Bench to Bedside I
- Cancer Immunotherapy and Cancer Stem Cells
- From Bench to Bedside II
- New Tools and Technologies
- Organoids and Stem Cell Engineering
- Presidential Symposium
- Disease Modeling
- CNS + Eye
- Genomic charictarisation of pluripotent stem cells
- Vector Development
- Muscle, cardio and lung
- Molecular basis of developmental potential
- Gene Editing
- Cell therapy and replacement
- metabolic and lysosomal
- Regulation and control of pluripotency and lineage specificity
- Immuno and vaccines
Abstract Submission is now open!
SUBMISSION DEADLINE: Friday, 6 July, 2018
Present your research to an engaged audience that spans the full breadth of the stem cell field, from basic research to industry! More than half of the program is dedicated to selected abstracts to ensure that current research is featured.You must register for the meeting in order to submit an abstract. You will be able to submit your abstract as part of the congress registration process once payment is complete.
For additional abstract submission information, visit the ESCGT website.